STOCK TITAN

Medwellai (MWAI) Financials

MWAI OTC
FY2026 annual
Revenue $528K -11.2% YoY
Net Income -$1.6M n/m YoY
EPS (Diluted) -$0.25 n/m YoY
Free Cash Flow -$307K n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Sep 30, 2026 Reported Currency USD FYE June

Newest figures come from the 10-Q for Q1 FY2027, filed Nov 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MWAI SEC filings page.

Medwellai Inc (MWAI) reported $528K in revenue for fiscal year 2026, down 11.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MWAI FY2026

MWAI’s asset base has collapsed beneath expanding liabilities, while revenue remains too small to absorb operating losses.

From FY2023 to FY2026, total assets fell 97.9% while total liabilities rose 14.4%, so obligations did not contract with the asset base. By FY2026, liabilities equaled 5781.4% of assets and the current ratio was 0.0141, indicating a balance sheet dominated by claims due relative to recorded resources.

Reported operating cash flow of -$307K matched free cash flow of -$307K in FY2026, showing that the cash shortfall was operating in nature rather than primarily a reinvestment choice. The same close pairing appeared in FY2025: operating cash flow of -$849K versus free cash flow of -$851K, reinforcing that capital spending was not the main driver.

Operating margin improved to -234.2% in FY2026 even as revenue fell 11.2%, so the smaller loss rate reflects contraction in the loss base, not profitable scale. Revenue was only $528K against an operating loss of $1.24M, leaving the operating model structurally loss-making at its latest reported scale.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Medwellai Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

Medwellai Inc passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Interest Coverage At Risk
N/A

Medwellai Inc reported an operating loss of $1.2M against $52K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$76K
YoY-34.9%

Medwellai Inc generated $76K in revenue in Q1 2027. This represents a decrease of 34.9% from the same quarter a year earlier.

EBITDA
-$240K
YoYn/m

Medwellai Inc's EBITDA was -$240K in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net Income
-$287K
YoYn/m

Medwellai Inc reported a net loss of $287K in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

EPS (Diluted)
-$0.04
YoYn/m
QoQn/m

Medwellai Inc earned -$0.04 per diluted share (EPS) in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Cash & Debt
$180K
YoY-19.3%
QoQ+108.8%
5Y CAGR-23.5%
10Y CAGR+31.9%

Medwellai Inc held $180K in cash as of Q1 2027; no long-term debt figure is on record for that period.

Shares Outstanding
7M
YoY+4.8%
QoQ0.0%

Medwellai Inc had 7M shares outstanding in Q1 2027. This represents an increase of 4.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q1 2027.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin
100.0%
YoY+6.4pp

Medwellai Inc's gross margin was 100.0% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 6.4 percentage points from the same quarter a year earlier.

Operating Margin

Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q1 2027.

Capital Allocation

None of these metrics is reported for Q1 2027.

MWAI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly income statement
MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Revenue$76K-34.9%N/A$619K+119.9%$548K+283.8%$117K+10125.3%$169K-84.5%$281K-85.8%$143K-91.7%
Cost of Revenue$0-100.0%N/AN/AN/A$8Kn/mN/A$0-100.0%$0-100.0%
Gross Profit$76K-30.5%N/AN/AN/A$110K+9467.7%N/A$281K-64.2%$143K-74.3%
SG&A Expenses$316K-29.3%N/A$365K-67.7%$410K-34.4%$447K+33.4%$595K+65.3%$1.1M+370.6%$625K+227.4%
Operating Income-$246Kn/mN/A-$228Kn/m-$274Kn/m-$327Kn/m-$1.1Mn/m-$814K-354.1%-$315Kn/m
EBITDA-$240Kn/mN/A-$213Kn/m-$259K-367.7%-$319Kn/m-$1.1Mn/m-$795K-178.5%$97K-76.4%
Interest Expense$46K+255.1%N/A$13K+0.5%$14K+4.9%$13K-0.9%$14K+4.3%$13K-45.4%$13K-45.6%
Income Tax$0n/mN/A$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Net Income-$287Kn/mN/A-$240Kn/m-$288Kn/m-$652Kn/m-$1.1Mn/m-$589K-298.0%-$674Kn/m
EPS (Basic)-$0.04n/m-$0.06n/m-$0.04n/m-$0.05n/m-$0.10n/m-$0.18n/m-$0.10-$0.14n/m
EPS (Diluted)-$0.04n/m-$0.06n/m-$0.04n/m-$0.05n/m-$0.10n/m-$0.18n/m-$0.10-$0.13n/m
Diluted Shares (Avg)N/AN/AN/AN/AN/AN/A6M5M+25.7%

Not reported in any period shown, so not listed: R&D Expenses.

MWAI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly balance sheet
MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Total Assets$221K-59.9%$140K-82.6%$322K-83.0%$461K-83.6%$550K-84.0%$806K-79.6%$1.9M-68.2%$2.8M-48.3%
Current Assets$198K-18.0%$112K-73.3%$165K-78.5%$164K-89.1%$242K-86.3%$419K-83.9%$766K-62.0%$1.5M+4681.1%
Cash & Equivalents$180K-19.3%$86K-78.5%$130K-73.0%$138K-41.4%$223K-70.2%$401K+594.1%$482K+26.3%$235K+754.3%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Accounts Receivable$3K$9KN/AN/AN/AN/AN/AN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
GoodwillN/AN/AN/AN/AN/AN/A$670K$670K
Total Liabilities$8.5M+9.1%$8.1M+9.3%$8.0M+7.7%$7.9M-4.3%$7.8M-6.0%$7.4M-4.8%$7.4M+0.1%$8.3M+15.7%
Current Liabilities$8.3M+10.6%$8.0M+160.5%$7.8M+157.8%$7.7M+101.9%$7.5M+101.5%$3.1M-17.0%$3.0M-8.8%$3.8M+25.7%
Non-Current Liabilities$156K-35.7%$161K-96.3%$231K-94.8%$237K-94.7%$243K-94.6%$4.4M+6.0%$4.4M+7.2%$4.5M+8.3%
Total Equity-$8.3Mn/m-$8.0Mn/m-$7.7Mn/m-$7.5Mn/m-$7.2Mn/m-$6.6Mn/m-$5.5Mn/m-$5.5Mn/m
Retained Earnings-$90.6Mn/m-$90.3Mn/m-$89.9M-202.6%-$89.6Mn/m-$89.3Mn/m-$88.7Mn/m$87.5Mn/m-$87.0Mn/m

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

MWAI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly cash flow statement
MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Operating Cash Flow-$101Kn/m-$44Kn/m-$7Kn/m-$85Kn/m-$171Kn/m-$109Kn/m-$278Kn/m-$217Kn/m
Depreciation & Amortization$6K-26.3%$9K+57.9%$15K-23.4%$15K-96.5%$8K+197.5%$5K-99.2%$19K-97.3%$412K-44.7%
Stock-Based Compensation$0-100.0%N/AN/AN/A$49Kn/mN/AN/AN/A
Capital ExpendituresN/A$0n/m$0n/mN/AN/A$0n/m$0n/m$0-100.0%
Free Cash FlowN/A-$44Kn/m-$7Kn/mN/AN/A-$109Kn/m-$278Kn/m-$217Kn/m
Investing Cash Flow$0n/m$0-100.0%$0-100.0%-$750n/m-$7K-100.8%$28K-95.7%$526K-61.4%-$299K-121.6%
Financing Cash Flow$195Kn/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MWAI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MWAI quarterly financial ratios
MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-Q
Gross Margin100.0%+6.4ppN/AN/AN/A93.6%-6.4ppN/A100.0%+60.4pp100.0%+67.8pp
Operating Margin-321.9%N/A-36.8%-50.0%-278.8%-662.4%-289.4%-220.6%
Net Margin-375.9%N/A-38.8%-52.4%-555.3%-666.0%-209.2%-471.7%
Return on Assets-130.2%-11.7ppN/A-74.7%-43.6pp-62.4%-38.5pp-118.5%-83.2pp-140.1%-79.7pp-31.1%-36.1pp-23.9%-17.3pp
Current Ratio0.020.0x0.01-0.1x0.02-0.2x0.02-0.4x0.03-0.4x0.14-0.6x0.25-0.4x0.40+0.4x
Asset Turnover0.35+0.1xN/A1.92+1.8x1.19+1.1x0.21+0.2x0.21-0.1x0.15-0.2x0.05-0.3x
FCF MarginN/AN/A-1.2%+97.7ppN/AN/A-64.2%+20.8pp-98.9%-52.8pp-151.7%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$8.0M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Medwellai Inc MWAI FY2026 $528K -$1.6M N/A N/A —
FDCTech Inc FDCT FY2025 $35.0M $5.8M 16.6% $501.3M —
NetBrands Corp NBND FY2025 $18K -$1.7M N/A $375K —
Hawkeye Digital Inc HWKE FY2026 $0 -$573K N/A $231.5M —

Frequently Asked Questions

Medwellai Inc (MWAI) reported $528K in total revenue for fiscal year 2026. This represents a -11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Medwellai Inc (MWAI) revenue declined by 11.2% year-over-year, from $595K to $528K in fiscal year 2026.

No, Medwellai Inc (MWAI) reported a net loss of $1.6M in fiscal year 2026.

Medwellai Inc (MWAI) reported diluted earnings per share of -$0.25 for fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Medwellai Inc (MWAI) had EBITDA of -$1.2M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Medwellai Inc (MWAI) recorded an outflow of $307K in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Medwellai Inc (MWAI) recorded an outflow of $307K in operating cash flow during fiscal year 2026, representing cash used by core business activities.

Medwellai Inc (MWAI) had $140K in total assets as of fiscal year 2026, including both current and long-term assets.

Medwellai Inc (MWAI) reported no capital expenditure during fiscal year 2026.

Medwellai Inc (MWAI) had 7M shares outstanding as of fiscal year 2026.

Medwellai Inc (MWAI) had a current ratio of 0.01 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

Medwellai Inc (MWAI) had a return on assets of -1131.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Medwellai Inc (MWAI) has negative shareholder equity of -$8.0M as of fiscal year 2026, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Medwellai Inc (MWAI) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Medwellai Inc (MWAI) reported an operating loss of $1.2M against $52K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top